Pharmaceutical Sales Representative - Biopharma
About the job
- Some sales abilities or sales experience in a quota-driven role.
- Some education and/or knowledge of pharmaceutical and healthcare products.
- Demonstrated sustained, high performance in the current position or a strong aptitude for learning.
- A high sense of urgency, particularly with regard to customer service orientation.
- Strong business acumen and ability to understand market opportunities.
- Ability to thrive in a highly driven, performance-based, fast-paced, and results-oriented culture.
- Ability to maintain a high degree of integrity and act ethically at all times.
- Promote and sell products to current and potential customers within a defined geography.
- Develop, analyze, prioritize, and execute territory plans to achieve business results through compliant means.
- Use functional and technical knowledge of pharmacology products, healthcare, pharmaceutical marketplaces, managed care, and customer markets to meet or exceed customer needs; understand and execute sales territory management and customer development.
- Establish and maintain excellent communications and sound working relationships with physicians and healthcare providers.
- Actively participate in scheduled company sales meetings, district and regional conference calls, and other business meetings.
- Model behaviors consistent with company standards and policies for business and compliance-related matters.
- Perform other related duties as required.
- Strong knowledge of the business and market in the assigned territory.
About the company
Prism Biotech provides field sales and medical affairs services to support pharmaceutical launches. It deploys pharmaceutical sales reps and medical science liaisons before product approval to collect prescriber information through office visits. The data gathered is combined with existing records to create a profile of key prescriber targets and disease states. This profiling happens before a launch so the sales team is prepared with identified targets and relevant physician insights. Prism Biotech differentiates itself by offering a full-service prelaunch target physician profiling workflow, aligning early market intelligence with product planning. The company’s goal is to prime and ready the sales force with accurate, ready-to-target physician profiles ahead of a brand’s approval and launch.
Company Size
N/A
Company Stage
N/A
Total Funding
N/A
Headquarters
Upper Merion Township, Pennsylvania
Founded
2019
Get referred to Prism Biotech
See people who can refer or advise you
Simplify's Take
What believers are saying
- Ono paid PRISM a milestone in November 2025, validating PepMetics execution.
- E7386 Phase 1 results were published in January 2026, extending clinical credibility.
- March 2026 Receptor.AI deal adds AI-driven discovery leverage for difficult targets.
What critics are saying
- August 2026 nine-month loss widened to ¥845.7 million; burn remains heavy.
- Servier terminated its collaboration in October 2025, proving partner churn hits PRISM.
- September 2026 cash burn and no guidance set up a dilutive 2027 financing crunch.
What makes Prism Biotech unique
- PepMetics targets intracellular protein-protein interactions, a hard, scarce drug-discovery niche.
- PRISM BioLab monetizes by out-licensing programs to Eisai, Ono, and Servier.
- 2026 collaborations with Receptor.AI and Talus deepen platform optionality.
Help us improve and share your feedback! Did you find this helpful?